DCLD Solicits Comments On Quality Control Portion Of CLIA Waiver Guidance
This article was originally published in The Gray Sheet
Executive Summary
The Center for Devices and Radiological Health is looking to revise the quality control portion of the interim CLIA draft guidance.
You may also be interested in...
CLIA Waiver Authority Shifts To FDA; IVD Office Ready To Test New Methods
CDRH is encouraging manufacturers to work with its in vitro diagnostics office to pilot new ways to meet CLIA waiver criteria
CLIA Waiver Authority Shifts To FDA; IVD Office Ready To Test New Methods
CDRH is encouraging manufacturers to work with its in vitro diagnostics office to pilot new ways to meet CLIA waiver criteria
CLIA Guidance Allows Firms To Gain Waiver Through User Comparison Studies
Manufacturers seeking waived status for diagnostic tests under user-based criteria will need to perform agreement studies with at least 300 untrained users to show that those users obtain the same results as lab professionals, according to an FDA draft guidance issued Jan. 23.